• Skip to primary navigation
  • Skip to main content
Engineered Tissue Solutions

Engineered Tissue Solutions

  • Chronic Wound Care
    • Mirragen
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Surgical Wound Care
    • MirraSurg
    • Clinical Evidence
    • ETS Case Studies
    • Testimonials
  • Science & Technology
  • Provider & Patient Support
    • For Providers
    • For Patients
    • Reimbursement
  • About
    • Contact Us
    • News & Events
    • Careers
    • Testimonials
  • Request Information

Case Study: Fungating Basal Cell Carcinoma


Patient History

  • 75-year-old male with basal cell carcinoma
  • Diabetes
  • Coronary artery disease

Treatment

  • Wide location excision of basal cell carcinoma
  • Application of MirraSurgTM and secondary dressing
  • Secondary dressing change, residual MirraSurg
  • moistened with saline with secondary dressing
  • Fully granulated at 3 weeks
  • Definitive closure with autologous skin graft
Preoperative
Intraoperative Excision Defect
Intraoperative MirraSurg Application
Autologous skin graft
application

Learn how ETS is transforming wound care.

Access Literature
  • Request Information
  • Contact Us
  • Careers
  • LinkedIn
  • Facebook
  • Instagram
  • Disclaimer
  • Privacy
  • Terms & Conditions
  • Patents

MIRRAGEN® is a registered trademark of ETS Tech Holdings, LLC. | © ETS Wound Care